Follow the Money / Can the Institute of Medicine Review the FDA? Wed, 6 Apr 2005 A letter to the editor published in Nature Medicine by Dr. Bernard Carroll, a past chairman of the FDA Advisory Committee for Psychotropic Drugs, and past chairman of the Department of Psychiatry at Duke…
Rutherford Files Mental Health Screening Lawsuit_Indiana / Fierce Opposition to TeenScreen Mounts – Pittsburgh Mon, 19 Sep 2005 The Rutherford Institute has just filed a lawsuit in Indiana challenging a school for subjecting a teenager to a mental health screening test – TeenScreen–without her parents’ knowledge or consent. After completing…
The Children’s Hospital of Philadelphia Department of Anesthesiology and Critical Care Medicine Robert M. Nelson, M.D., Ph.D. 34th Street & Civic Center Boulevard, Rm. 1513 Chair, Committees for the Protection of Human Subjects Philadelphia, Pennsylvania 19104-4399 Associate Professor of Anesthesia and Pediatrics (215) 590-9180 Office (267) 426-5035 Fax November 25,…
Accutane Suicide Controversy–small study finds depression reduced Tue, 17 May 2005 Accutane–a drug prescribed for acne has been linked to suicide and birth defects–it carries bold warnings about birth defects. A small non-blinded study finding is being touted by Hoffman-La Roche, manufacturer of Accutane. The study found the drug did…
Lilly's aggressive marketing of Xigris does indeed epitomize the worst ofthis industry's mission.
"Academic officials acknowledged in the published guidelines that Lilly gave more than 90 percent of $861,000 in grants for the campaign and medical recommendations. About a fifth of the 46 guidelines writers acknowledged previously taking money from Eli Lilly for speaking, consulting or research."
FDA's Dr. Steven Galson, like his predecessor who now occupies a position in the Commissioner's office, demonstrates disconnectedness from reality, much like Nero who fiddled while Rome burned…
A Special Article By Curt D. Furberg, MD, PhD; Arthur A. Levin, MPH; Peter A. Gross, MD; Robyn S. Shapiro, JD; Brian L. Strom, MD, MPH
FDA issued an advisory stating that the concealed study results demonstrate "that use of Trasylol may increase the chance for death, serious kidney damage, congestive heart failure and strokes."
"This is really an ethical Potemkin village, where a hollow system appears to provide the illusion of integrity, but transgressors never leave."
Evidence of an association between violence and widely prescribed antidepressant drugs is the focus of this Infomail.
The Los Angeles Times has uncovered yet additional evidence of financial misconduct and corrupt practices at the National Institutes of Health (NIH).
